Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function

Head and Neck

Volumn 34, Issue 2, 2012, Pages 146-154

  Leonhardt, Fernando Danelon ^a   Quon, Harry ^b   Abrahão, Marcio ^a   O'Malley Jr , Bert W ^c   Weinstein, Gregory S ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

functional status; oropharynx carcinoma; postoperative chemoradiation; postoperative radiotherapy; quality of life; transoral robotic surgery (TORS)

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIET; FEMALE; FOOD INTAKE; HUMAN; MALE; ORAL SURGERY; OROPHARYNX CARCINOMA; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; ROBOTICS; SELF REPORT; SPEECH; SQUAMOUS CELL CARCINOMA; TRANSORAL ROBOTIC SURGERY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH STATUS INDICATORS; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; ROBOTICS; TREATMENT OUTCOME; XEROSTOMIA;

EID: 84855646939     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21688     Document Type: Article

References (31)

1. List M, Lee Rutherford J, Stracks J,. An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck. Cancer 2002; 95: 98-104. (Pubitemid 34743487)
2. Hammerlid E, Bjordal K, Ahlner-Elmqvist M, et al. A prospective study of quality of life in head and neck cancer patients. Part I: At diagnosis. Laryngoscope 2001; 111: 669-680. (Pubitemid 32295283)
3. Funk G, Karnell L, Dawson C, et al. Baseline and post-treatment assessment of the general health status of head and neck cancer patients compared with United States population norms. Head Neck 1997; 19: 675-683. (Pubitemid 27495307)
4. deGraeff A, de Leeuw J, Ros W, et al. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 2000; 22: 398-407. (Pubitemid 30413307)
5. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, et al. A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 2001; 111: 1440-1452. (Pubitemid 32730193)
6. McKinstry A, Perry A,. Evaluation of speech in people with head and neck cancer: a pilot study. Int J Lang Commun Disord 2003; 38: 31-46. (Pubitemid 36216367)
7. Fung K, Terrell J,. Outcomes research in head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2004; 66: 207-213. (Pubitemid 39370458)
8. Hammerlid E, Taft C,. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 2001; 84: 149-156. (Pubitemid 32113438)
9. Colangelo L, Logemann J, Pauloski B,. T stage and functional outcome in oral and oropharyngeal cancer patients. Head Neck 1996; 18: 259-268. (Pubitemid 26124039)
10. Rogers S, Lowe D, Fisher S, et al. Health-related quality of life and clinical function after primary surgery for oral cancer. Br J Oral Maxillofac Surg 2002; 40: 11-18. (Pubitemid 34257276)
11. Seikaly H, Rieger J, Wolfaardt J, et al. Functional outcomes after primary oropharyngeal cancer resection and reconstruction with the radial forearm free flap. Laryngoscope 2003; 113: 897-904. (Pubitemid 36539167)
12. O'Brien CJ, Lee KK, Castle GK, Hughes CJ,. Comprehensive treatment strategy for oral and oropharyngeal cancer. Am J Surg 1992; 164: 582-586.
13. Weinstein GS, O'Malley BW Jr, Snyder W, Sherman E, Quon H,. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 2007; 133: 1220-1226. (Pubitemid 350294250)
14. List M, Ritter-Sterr C, Landsky S,. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 564-569. (Pubitemid 20233457)
15. Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H,. Transoral robotic surgery (TORS) for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010. Accepted for publication.
16. O'Brien CJ, Traynor S, MacNeil E, McMahon J, Chaplin J,. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 2000; 126: 360-365. (Pubitemid 30144020)
17. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952. (Pubitemid 38580197)
18. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
19. Pignon J-P, le Matre A, Bourhis J,. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 2007; 69 (Suppl 1): S112-S114. (Pubitemid 47369400)
20. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 843-854. (Pubitemid 44292807)
21. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
22. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ,. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008; 26: 3770-3776.
23. Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 401-408. (Pubitemid 38456313)
24. O'Malley BW Jr, Weinstein G, Snyder W, Hockstein N,. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006; 116: 1465-1472. (Pubitemid 44181466)
25. Dosoretz A, Dutta P, Alonso-Basanta M, et al. Long-term percutaneous gastrostomy tube dependence rates in patients treated with intensity-modulated radiotherapy for oropharyngeal cancer: the University of Pennsylvania experience. In: ASTRO Multidisciplinary Head and Neck Cancer Symposium, 2009; Chandler, Arizona.
26. Ruo Redda MG, Allis S,. Radiotherapy-induced taste impairment. Cancer Treat Rev 2006; 32: 541-547. (Pubitemid 44467743)
27. Li Y, Taylor JM, Ten Haken RK, Eisbruch A,. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 2007; 67: 660-669. (Pubitemid 46215864)
28. Hassanein K, Musgrove B, Bradbury E,. Functional status of patients with oral cancer and its relation to style of coping, social support and psychological status. Br J Oral Maxillofac Surg 2001; 39: 340-345. (Pubitemid 33076730)
29. Evans D, Charney D, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005; 58: 175-189. (Pubitemid 41112265)
30. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993; 26: 3-11. (Pubitemid 23137882)
31. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.